While our study focuses on the role of IGFBP5 in skeletal muscle fibrosis and sarcopenia, its involvement in fibrosis extends to multiple tissues and disease states, highlighting its potential as a therapeutic target. Here, IGFBP5 is linked to sarcopenia.